NIH-funded research NIH-funded research

HIV laboratory support network

Official title: AIDS Clinical Trial Group Laboratory Center

Funded at University of California Los Angeles · NIH-11524690 · Data updated 2026-11-12

This program runs advanced lab testing and training to help develop and improve treatments for people living with HIV.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of California Los Angeles
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startJanuary 1, 2014
Project endNovember 30, 2027
Funding year2026
Award (this year)$799,305
NIH project number3UM1AI106701-13S1
Project IDNIH-11524690 on NIH RePORTER

Who could benefit from this research

Could help

People living with HIV — including those with TB, hepatitis B, or neurologic complications — who are eligible for or interested in ACTG clinical trials or willing to provide samples at an affiliated site.

Less likely to help

People without HIV, or those who cannot or will not enroll at an ACTG-affiliated clinic, are unlikely to see direct benefits from this lab program.

What this research studies

If I have HIV, this program helps make sure the lab tests used in clinical trials are accurate, standardized, and up-to-date. It supports labs at many U.S. and international sites, provides assay development for virology, immunology, pharmacology, genomics, and tuberculosis, and offers quality assurance and training. The center works with statisticians and data managers to link lab results to clinical trials and to support trials targeting HIV remission, novel therapies, and co-infections like TB and hepatitis B. Its work underpins the laboratory backbone needed for safe and informative interventional studies.

Why it matters

Potential benefit: Could speed safer, more effective HIV treatments and improved testing for co-infections like tuberculosis and hepatitis B.

How similar studies have gone: The ACTG laboratory network has decades of successful work that helped establish current HIV treatment guidelines, so this continues a proven effort.

Where this research is happening

  • University of California Los Angeles
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Aldrovandi, Grace M — University of California Los Angeles
  • Study coordinator: Aldrovandi, Grace M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.